<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Medtech &#8211; Somerset Indus Capital Partners</title>
	<atom:link href="https://somersetinduscap.com/tag/medtech/feed/" rel="self" type="application/rss+xml" />
	<link>https://somersetinduscap.com</link>
	<description></description>
	<lastBuildDate>Thu, 05 May 2022 06:23:20 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://somersetinduscap.com/wp-content/uploads/2020/06/cropped-logo_somerest-32x32.png</url>
	<title>Medtech &#8211; Somerset Indus Capital Partners</title>
	<link>https://somersetinduscap.com</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>GenWorks Health raises Rs 135 Cr from Somerset Indus Capital Partners, Morgan Stanley, Evolvence &#038; Wipro GE</title>
		<link>https://somersetinduscap.com/genworks-health-raises-rs-135-cr-from-somerset-indus-capital-partners-morgan-stanley-evolvence-wipro-ge/</link>
		
		<dc:creator><![CDATA[somerse_wp-capital]]></dc:creator>
		<pubDate>Thu, 05 May 2022 06:23:20 +0000</pubDate>
				<category><![CDATA[News]]></category>
		<category><![CDATA[Genworks]]></category>
		<category><![CDATA[Medical devices]]></category>
		<category><![CDATA[Medtech]]></category>
		<guid isPermaLink="false">https://somersetinduscap.com/?p=8133</guid>

					<description><![CDATA[GenWorks said it aims to double revenues in FY23 and the funding will be leveraged to cover working capital needs, relevant M&#038;A to invest in manufacturing partnerships, and expansion in the area of in-vitro diagnostics. GenWorks, the Bengaluru-based startup that is dedicated to improving healthcare access in India, has raised a second round of funding [&#8230;]]]></description>
										<content:encoded><![CDATA[<p>GenWorks said it aims to double revenues in FY23 and the funding will be leveraged to cover working capital needs, relevant M&#038;A to invest in manufacturing partnerships, and expansion in the area of in-vitro diagnostics.</p>
<p>GenWorks, the Bengaluru-based startup that is dedicated to improving healthcare access in India, has raised a second round of funding to the tune of Rs 135 crore from investors such as Somerset Indus Capital Partners, Morgan Stanley through its funding arm Grand Vista, Evolvence and Wipro GE.</p>
]]></content:encoded>
					
		
		
			</item>
	</channel>
</rss>
